First Time Loading...

Bicycle Therapeutics PLC
NASDAQ:BCYC

Watchlist Manager
Bicycle Therapeutics PLC Logo
Bicycle Therapeutics PLC
NASDAQ:BCYC
Watchlist
Price: 24.58 USD -0.45% Market Closed
Updated: May 4, 2024

Bicycle Therapeutics PLC
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bicycle Therapeutics PLC
Cash from Financing Activities Peer Comparison

Comparables:
CNTA
EXAI
AUTL
IMCR
GNS

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Bicycle Therapeutics PLC
NASDAQ:BCYC
Cash from Financing Activities
$250m
CAGR 3-Years
22%
CAGR 5-Years
58%
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Cash from Financing Activities
$21.1m
CAGR 3-Years
149%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Exscientia PLC
NASDAQ:EXAI
Cash from Financing Activities
-£3.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Cash from Financing Activities
-$883k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Cash from Financing Activities
£34.3m
CAGR 3-Years
-33%
CAGR 5-Years
221%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Cash from Financing Activities
-£20.5m
CAGR 3-Years
5%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Bicycle Therapeutics PLC's Cash from Financing Activities?
Cash from Financing Activities
250m USD

Based on the financial report for Mar 31, 2024, Bicycle Therapeutics PLC's Cash from Financing Activities amounts to 250m USD.

What is Bicycle Therapeutics PLC's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
58%

Over the last year, the Cash from Financing Activities growth was 2 690%. The average annual Cash from Financing Activities growth rates for Bicycle Therapeutics PLC have been 22% over the past three years , 58% over the past five years .